Ningbo Menovo Pharmaceutical Co., Ltd. (SHA:603538)
18.46
+1.68 (10.01%)
Jun 20, 2025, 3:00 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Intermediates and Raw Materials | 747.07M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Intermediates and Raw Materials Growth | 9.72% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Preparation | 220.93M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Preparation Growth | -0.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Contract Development and Manufacturing Organization | 200.52M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Contract Development and Manufacturing Organization Growth | -60.23% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Trading | 40.18M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Trading Growth | 25.65% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Business | 7.79M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Business Growth | -55.14% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medicine Circulation | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medicine Circulation Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Hypotension | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Hypotension Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Central Nervous System | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Central Nervous System Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Antithrombic | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Antithrombic Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Hypolipidemic | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Health Lipids | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Overseas | 733.79M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Overseas Growth | 39.27% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China | 474.91M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China Growth | -47.97% |
Log In |
Log In |
Log In |
Log In | Upgrade
|